Helius Medical Technologies Share Price (NASDAQ: HSDT)

$6.28

▲

0.25

(4.15%)

Live

Last updated on August 18, 2025 at 11:46 PM IST

$₹

Check the interactive Helius Medical Technologies Stock chart to analyse performance

Helius Medical Technologies stock performance

as on August 18, 2025 at 11:46 PM IST

Today's Low:$6.06
Today's High:$6.30
$6.28
3.5%
Downside
Day's Volatility :3.81%
Upside
0.32%
52 Weeks Low:$5.37
52 Weeks High:$1,200.00
$6.28
14.49%
Downside
52 Weeks Volatility :99.55%
Upside
99.48%

Helius Medical Technologies Stock Returns

Period	Helius Medical Technologies Inc	Index (Russel 2000)
3 Months	-97.49%	0.0%
6 Months	-98.54%	0.0%
1 Year	-98.87%	0.0%
3 Years	-99.97%	-11.6%

Helius Medical Technologies Inc Key Stats

Check Helius Medical Technologies key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$6.03
Open	$5.9
Today's High	$6.3
Today's Low	$6.06
Market Capitalization	$4.2M
Today's Volume	$18.3K
52 Week High	$1200.0
52 Week Low	$5.37
Revenue TTM	$295.0K
EBITDA	$-13.8M
Earnings Per Share (EPS)	$-1320.0
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-344.28%

Stock Returns calculator for Helius Medical Technologies Stock including INR - Dollar returns

The Helius Medical Technologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Helius Medical Technologies investment value today

Current value as on today

₹5,246

Returns

₹94,754

(-94.75%)

Returns from Helius Medical Technologies Stock

₹98,827 (-98.83%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards Helius Medical Technologies Stock

-63.95%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Investment in Helius Medical Technologies Shares from India has dropped by -63.95% over the past 30 days, indicating reduced transactional activity.

-56%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Helius Medical Technologies Stock from India on INDmoney has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Helius Medical Technologies Inc

Name
Holdings %
Name
Holdings %
Grant Private Wealth Management Inc
0.01%

Analyst Recommendation on Helius Medical Technologies Stock

Rating

Trend

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Helius Medical Technologies(by analysts ranked 0 to 5 stars)

Helius Medical Technologies Share Price Target

What analysts predicted

Downside of 36.31%

Target:

$4.00

Current:

$6.28

Helius Medical Technologies share price target is $4.00, a slight Downside of 36.31% compared to current price of $6.28 as per analysts' prediction.

Helius Medical Technologies Stock Insights

Price Movement
In the last 1 month, HSDT stock has moved down by -32.2%
Decreasing Revenue
Revenue is down for the last 2 quarters, 152.0K → 49.0K (in $), with an average decrease of 67.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -3.92M → -3.83M (in $), with an average increase of 2.3% per quarter
HSDT vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 31.8% return, outperforming this stock by 130.7%
HSDT vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 142.0% return, outperforming this stock by 242.0%
Price to Sales
ForHSDT every $1 of sales, investors are willing to pay $0.7, whereas for Boston Scientific Corp., the investors are paying $8.2 for every $1 of sales.

Helius Medical Technologies Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$1.5M	↑ 212.97%
Net Income	$-9.8M	↓ 65.83%
Net Profit Margin	-653.81%	↑ 5334.27%

	FY20	Y/Y Change
Revenue	$661.0K	↓ 55.82%
Net Income	$-14.1M	↑ 44.46%
Net Profit Margin	-2.1K%	↓ 1483.86%

	FY21	Y/Y Change
Revenue	$522.0K	↓ 21.03%
Net Income	$-18.1M	↑ 28.32%
Net Profit Margin	-3.5K%	↓ 1335.89%

	FY22	Y/Y Change
Revenue	$787.0K	↑ 50.77%
Net Income	$-14.1M	↓ 22.39%
Net Profit Margin	-1.8K%	↑ 1685.5%

	FY23	Y/Y Change
Revenue	$644.0K	↓ 18.17%
Net Income	$-8.9M	↓ 37.11%
Net Profit Margin	-1.4K%	↑ 413.84%

	FY24	Y/Y Change
Revenue	$520.0K	↓ 19.25%
Net Income	$-11.7M	↑ 32.68%
Net Profit Margin	-2.3K%	↓ 883.86%

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

	Q4 FY23	Q/Q Change
Revenue	$134.0K	↓ 6.29%
Net Income	$-1.0M	↓ 71.47%
Net Profit Margin	-779.85%	↑ 1781.69%

	Q1 FY24	Q/Q Change
Revenue	$135.0K	↑ 0.75%
Net Income	$-2.5M	↑ 140.77%
Net Profit Margin	-1.9K%	↓ 1083.85%

	Q2 FY24	Q/Q Change
Revenue	$182.0K	↑ 34.81%
Net Income	$-1.6M	↓ 35.93%
Net Profit Margin	-885.71%	↑ 977.99%

	Q3 FY24	Q/Q Change
Revenue	$51.0K	↓ 71.98%
Net Income	$-3.7M	↑ 128.66%
Net Profit Margin	-7.2K%	↓ 6341.74%

	Q4 FY24	Q/Q Change
Revenue	$152.0K	↑ 198.04%
Net Income	$-3.9M	↑ 6.57%
Net Profit Margin	-2.6K%	↑ 4643.24%

	Q1 FY25	Q/Q Change
Revenue	$49.0K	↓ 67.76%
Net Income	$-3.8M	↓ 2.29%
Net Profit Margin	-7.8K%	↓ 5248.44%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$586.0K	↑ 39.86%

	FY20	Y/Y Change
Profit	$-90.0K	↓ 115.36%

	FY21	Y/Y Change
Profit	$224.0K	↓ 348.89%

	FY22	Y/Y Change
Profit	$324.0K	↑ 44.64%

	FY23	Y/Y Change
Profit	$61.0K	↓ 81.17%

	FY24	Y/Y Change
Profit	$-62.0K	↓ 201.64%

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

	Q4 FY23	Q/Q Change
Profit	$44.0K	↓ 157.89%

	Q1 FY24	Q/Q Change
Profit	$12.0K	↓ 72.73%

	Q2 FY24	Q/Q Change
Profit	$64.0K	↑ 433.33%

	Q3 FY24	Q/Q Change
Profit	$-136.0K	↓ 312.5%

	Q4 FY24	Q/Q Change
Profit	$-2.0K	↓ 98.53%

	Q1 FY25	Q/Q Change
Profit	$-72.0K	↑ 3500.0%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-21.0M	↑ 7.02%
Investing Cash Flow	$-769.0K	↑ 74.77%
Financing Cash Flow	$1.7M	↓ 95.87%

	FY20	Y/Y Change
Operating Cash Flow	$-11.7M	↓ 44.1%
Investing Cash Flow	$-9.0K	↓ 98.83%
Financing Cash Flow	$9.6M	↑ 483.06%

	FY21	Y/Y Change
Operating Cash Flow	$-13.4M	↑ 14.06%
Investing Cash Flow	$-56.0K	↑ 522.22%
Financing Cash Flow	$21.1M	↑ 119.19%

	FY22	Y/Y Change
Operating Cash Flow	$-14.3M	↑ 6.89%
Investing Cash Flow	$-11.0K	↓ 80.36%
Financing Cash Flow	$17.9M	↓ 15.42%

	FY23	Y/Y Change
Operating Cash Flow	$-10.4M	↓ 27.21%
Investing Cash Flow	$-29.0K	↑ 163.64%
Financing Cash Flow	$1.1M	↓ 93.97%

	FY24	Y/Y Change
Operating Cash Flow	$-11.0M	↑ 6.0%
Investing Cash Flow	$-5.0K	↓ 82.76%
Financing Cash Flow	$7.0M	↑ 545.68%

Q4 FY23

Q1 FY24

	Q4 FY23	Q/Q Change
Operating Cash Flow	$-2.0M	↓ 17.05%
Investing Cash Flow	$-3.0K	↓ 50.0%
Financing Cash Flow	$622.0K	↑ 36.7%

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-3.0M	↑ 47.54%
Investing Cash Flow	$-5.0K	↑ 66.67%
Financing Cash Flow	$1.5M	↑ 135.21%

Helius Medical Technologies Technicals Summary

Sell

Neutral

Buy

Helius Medical Technologies is currently in a neutral trading position according to technical analysis indicators.

Helius Medical Technologies Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Helius Medical Technologies Inc	-37.06%	-98.54%	-98.87%	-99.97%	-100.0%
Medtronic Plc	3.7%	8.07%	9.67%	-2.08%	-7.74%
Edwards Lifesciences Corp.	2.22%	3.42%	14.65%	-20.59%	-0.65%
Boston Scientific Corp.	-0.59%	-2.07%	31.13%	145.53%	162.19%
Stryker Corporation	-1.4%	-0.96%	11.98%	75.08%	105.22%
Abbott Laboratories	5.89%	1.21%	17.74%	19.71%	31.12%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Helius Medical Technologies Inc	0.14	NA	0.0	0.0	-3.44	-1.08	NA	8.86
Medtronic Plc	25.51	25.51	2.16	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	32.74	32.74	4.68	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	61.41	61.41	1.79	2.98	0.12	0.05	NA	15.14
Stryker Corporation	50.52	50.52	2.17	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.53	16.53	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Helius Medical Technologies Inc	Buy	$4.2M	-100.0%	0.14	0.0%
Medtronic Plc	Buy	$118.0B	-7.74%	25.51	13.9%
Edwards Lifesciences Corp.	Buy	$45.9B	-0.65%	32.74	72.96%
Boston Scientific Corp.	Buy	$152.9B	162.19%	61.41	13.55%
Stryker Corporation	Buy	$146.0B	105.22%	50.52	12.25%
Abbott Laboratories	Buy	$229.3B	31.12%	16.53	32.43%

About Helius Medical Technologies Inc

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

Organization	Helius Medical Technologies
Employees	21
CEO	Mr. Dane Carl Andreeff
Industry	Health Technology

Key Management of Helius Medical Technologies Inc

Name	Title
Mr. Dane Carl Andreeff	President, CEO & Director
Dr. Antonella Favit-Van Pelt M.D., Ph.D.	Chief Medical Officer
Mr. Lawrence Picciano	Senior Vice President of Engineering, Quality & Regulatory Affairs

Important FAQs about investing in HSDT Stock from India :

What is Helius Medical Technologies share price today?

Helius Medical Technologies share price today is $6.28 as on August 18, 2025 at 11:46 PM IST. Helius Medical Technologies share today touched a day high of $6.30 and a low of $6.06.

What is the 52 week high and 52 week low for Helius Medical Technologies share?

Helius Medical Technologies share touched a 52 week high of $1,200.00 and a 52 week low of $5.37. Helius Medical Technologies stock price today, August 18, 2025 at 11:46 PM IST is trending at $6.28, lower by 99.48% versus the 52 week high.

How to invest in Helius Medical Technologies Stock (HSDT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Helius Medical Technologies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Helius Medical Technologies Shares that will get you 0.2389 shares as per Helius Medical Technologies share price of $6.28 per share as on August 18, 2025 at 11:46 PM IST.

What is the minimum amount required to buy Helius Medical Technologies Stock (HSDT) from India?

Indian investors can start investing in Helius Medical Technologies (HSDT) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Helius Medical Technologies stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Helius Medical Technologies share’s latest price of $6.28 as on August 18, 2025 at 11:46 PM IST, you will get 1.5924 shares of Helius Medical Technologies. Learn more about fractional shares .

What are the returns that Helius Medical Technologies has given to Indian investors in the last 5 years?

Helius Medical Technologies stock has given -100.0% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?